Ganaxolone (Compound)

Synonyms:GANAXOLONE, 38398-32-2, CCD 1042, Ztalmy, CCD-1042, 3alpha-Hydroxy-3beta-methyl-5alpha-pregnan-20-one, 1-((3R,5S,8R,9S,10S,13S,14S,17S)-3-Hydroxy-3,10,13-trimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethanone, 98WI44OHIQ, 1-[(3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone, DTXSID6046503, DEA NO. 2401, C22H36O2, Pregnan-20-one, 3-hydroxy-3-methyl-, (3a,5a)-, NCGC00165802-02, (3alpha,5alpha)-3-hydroxy-3-methyl-pregnan-20-one, DTXCID4026503, 1-((3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethan-1-one, CAS-38398-32-2, Ganaxolone [USAN], Ganaxolone [USAN:INN], UNII-98WI44OHIQ, Ganaxolone, solid, GANAXOLONE [MI], GANAXOLONE [INN], Ganaxolone (USAN/INN), GANAXOLONE [WHO-DD], SCHEMBL144522, (3alpha,5alpha)-3-Hydroxy-3-methylpregnan-20-one, CHEMBL1568698, GTPL11942, CCD1042, CHEBI:177658, HMS3261K19, AMY38916, Tox21_112264, Tox21_500379, BDBM50369240, HB0938, MFCD09971088, AKOS027327586, Tox21_112264_1, CCG-221683, DB05087, LP00379, SDCCGSBI-0633706.P001, NCGC00165802-03, NCGC00261064-01, NCGC00263545-01, AS-35253, (3?,5?)-3-Hydroxy-3-methyl-pregnan-20-one, 3alpha-Hydroxy-3-methyl-5alpha-pregnan-20-one, D04300, A901692, Q3758034, 3.ALPHA.-HYDROXY-3-METHYL-5.ALPHA.-PREGNAN-20-ONE, Pregnan-20-one, 3-hydroxy-3-methyl-, (3alpha,5alpha)-, PREGNAN-20-ONE, 3-HYDROXY-3-METHYL-, (3.ALPHA.,5.ALPHA.)-, 1-[(3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone.

Pubchem:PUBCHEM:6918305

Id:ee531a92-f799-5c07-98d5-28941f07563a

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Ganaxolone's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Ganaxolone.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Ganaxolone.

Results found

Linked to

	Label	Description
	BRD-K28217197-001-01-4 Substance (Entity type)	A Substance
	DCSTRUCT ID 05508 Collection (Entity type)	DrugPage Collection: (DrugCentralID:05508; PubChem_CID:6918305, FILE=drugcentral_drug_05508.json)
	ganaxolone (ab6f72ca-5931-4c6e-8659-58e665f9ab54) Collection (Entity type)	Metadatata for ganaxolone
	Ganaxolone negatively regulates GBP1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ganaxolone positively regulates GPI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ganaxolone positively regulates LAPTM4B Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ganaxolone negatively regulates DNAJA3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ganaxolone positively regulates CASP10 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ebselen in similarity relationship with Ganaxolone Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	Ganaxolone positively regulates TXNDC9 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS